2014
Charcot Neuroarthropathy of the Foot and Ankle Diagnosis and Management Strategies
Blume PA, Sumpio B, Schmidt B, Donegan R. Charcot Neuroarthropathy of the Foot and Ankle Diagnosis and Management Strategies. Clinics In Podiatric Medicine And Surgery 2014, 31: 151-172. PMID: 24296023, DOI: 10.1016/j.cpm.2013.09.007.Peer-Reviewed Original Research
2013
Successful Treatment of a Proximal Type I Endoleak With HeliFX EndoAnchors
Hogendoorn W, Schlösser FJ, Aruny JE, Indes JE, Sumpio BE, Muhs BE. Successful Treatment of a Proximal Type I Endoleak With HeliFX EndoAnchors. Annals Of Vascular Surgery 2013, 28: 737.e13-737.e17. PMID: 24184495, DOI: 10.1016/j.avsg.2013.07.028.Peer-Reviewed Original ResearchConceptsProximal type IEndovascular aneurysm repairAbdominal aortic aneurysmAortic aneurysmPrevious endovascular aneurysm repairRuptured abdominal aortic aneurysmType IProximal extension cuffResidual type IViable treatment optionExtension cuffAneurysm repairEndovascular treatmentRenal arteryTreatment optionsSuccessful treatmentEndoAnchorsAneurysm sacEndoleakEndograftProximal siteAneurysmsTreatmentArteryCuff
2006
The management of deep sternal wound infections using vacuum assisted closure™ (V.A.C.®) therapy
Fleck T, Gustafsson R, Harding K, Ingemansson R, Lirtzman MD, Meites HL, Moidl R, Price P, Ritchie A, Salazar J, Sjögren J, Song DH, Sumpio BE, Toursarkissian B, Waldenberger F, Wetzel‐Roth W. The management of deep sternal wound infections using vacuum assisted closure™ (V.A.C.®) therapy. International Wound Journal 2006, 3: 273-280. PMID: 17199763, PMCID: PMC7951489, DOI: 10.1111/j.1742-481x.2006.00273.x.Peer-Reviewed Original ResearchConceptsDeep sternal wound infectionSternal wound infectionWound infectionV.A.C. therapyThorough wound irrigationPrinciples of treatmentVacuum-assisted closureTreatment of infectionsSurgical debridementClinical guidelinesEarly recognitionWound irrigationAssisted closureCurrent evidenceSurgical supervisionTherapyInfectionAdequate experienceInternational expertsTreatmentInternational groupDebridementGroupGroup discussionsClinicians
2000
Tissue Plasminogen Activator: Biological and Physiological Relevance for Vascular Surgeons
Chang R, Kamal K, Sumpio B. Tissue Plasminogen Activator: Biological and Physiological Relevance for Vascular Surgeons. 2000, 1315-1323. DOI: 10.1007/978-1-4612-1190-7_103.Peer-Reviewed Original ResearchTissue-type plasminogen activatorThrombolytic therapyDeep venous thrombosisOcclusive vascular diseaseEfficacy of treatmentCerebrovascular accidentPulmonary embolismVenous thrombosisClinical outcomesMyocardial infarctionVascular diseaseVascular surgeonsHuman trialsEffective treatmentThrombolytic agentsPlasminogen activatorTherapyPhysiological relevanceTreatmentEndogenous propertiesEmbolismInfarctionThrombosisPatientsAgents
1987
Comparison of effects of ATP-MgCl2 and adenosine-MgCl2 on renal function following ischemia
Sumpio BE, Hull MJ, Baue AE, Chaudry IH. Comparison of effects of ATP-MgCl2 and adenosine-MgCl2 on renal function following ischemia. American Journal Of Physiology 1987, 252: r388-r393. PMID: 3492930, DOI: 10.1152/ajpregu.1987.252.2.r388.Peer-Reviewed Original ResearchConceptsRenal functionATP-MgCl2Warm ischemiaATP-MgCl2 treatmentKrebs-HCO3 bufferMM ATP-MgCl2Comparison of effectsNormothermic ischemiaTransient improvementIschemiaSalutary effectsControl valuesUrine samplesFunctional parametersKidneyMajor breakdown productAdenosineTreatmentBreakdown productsMmHgPerfusateMinAdministration
1984
Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment.
Sumpio BE, Ernstoff MS, Kirkwood JM. Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment. Cancer Research 1984, 44: 3599-603. PMID: 6378373.Peer-Reviewed Original ResearchConceptsInterferon therapyUrinary excretionInterferon activityPhase I trialSerum interferon activityUrinary betaInterferon administrationI trialSignificant nephrotoxicityTubular lesionsUrinary levelsInterferon treatmentHighest dosing levelDosing levelsTherapyInterferonExcretionTreatmentLow affinityAlbuminBetaNephrotoxicityPatientsLesionsPharmacokinetics